2 ms·
I think a lot of the reason drug discovery and development takes so long, and requires patents to maintain commercial viability, is the government/FDA imposed r
by rdl 15y ago
I think a lot of the reason drug discovery and development takes so long, and requires patents to maintain commercial viability, is the government/FDA imposed regulatory requirement. While the basic research isn't included, it's not really the kind of stuff a drug company copies from another drug company, either -- the more product-specific discovery and development happens over a shorter time window, then you get ~10 years of clinical trials. The biggest risk if there weren't IP protection would be someone copying you during the clinical trial phase -- before you can sell it, but after most of the risk is eliminated (and money has been spent).
If we think the FDA is overall worthwhile (I think some kind of testing is key, but it could be more done by insurers for efficacy with the FDA focusing on safety, but the current system isn't horrible), I'd be willing to allow patents in that specific case, to compensate for the regulation.
There is not anywhere near as much societal benefit to third-party audited testing of one click or business process, so trade secret remains possible for a lot longer (at least until the product is fielded), at which point first mover advantage and constant innovation should be at least partially effective in compensating the inventor.
- ghshephard 15y ago"The biggest risk if there weren't IP protection would be someone copying you during the clinical trial phase" I think the biggest risk be other drug companies just waiting to see which drug was effective, and sold well, and then just copying the drugs that were effective/sold well.
- rdl 15y agoThe risk is definitely from the clinical trial stage through patent expiration -- I'm just saying it isn't at the early research stage. Marketing could possibly mitigate some of the risk once it's on the market (branded viagra vs. other drugs), especially in a world without the FDA (where you would have anxiety about the safety and efficacy of arbitrary drugs). Pre-launch, but after disclosure, there wouldn't be much of a way to differentiate yourself. Also, by the time the drug comes to market (after extended trials), the patent is well on its way to expiration. In 2010 they changed this so you get 12 years of exclusivity on the market. There are also lots of lame dirty tricks to refresh patents (slight changes in packaging, marketing, etc.) Without the FDA/testing, you could possibly keep the drug's composition secret even once it's on the market; you could reveal info under NDA, or reveal trials info without revealing the compound. You could even imagine a situation where possession of the substance is under license, so no one could try to reverse engineer it. I don't think that is necessarily better than what we have now, but this is a lot of why patents make sense in medicine more so than in software, even if they don't make sense in either or make sense in both.